We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

BOCHGR:ATHEXBank of Cyprus Holdings Plc Analysis

Data as of 2026-05-20 - not real-time

€9.36

Latest Price

4/10Risk

Risk Level: Medium

Executive Summary

Bank of Cyprus trades at €9.36, delivering a trailing P/E of 8.4 versus the industry average of 16.5, indicating a clear valuation discount. The price‑to‑book of 1.34 sits just above book value, reinforcing the undervalued picture. A dividend yield of 5.4% with a 61% payout ratio is backed by €9.28 bn of cash and a modest €1.37 bn debt load, suggesting sustainability. Operating margins of 57.7% and a profit margin of 47% demonstrate strong earnings efficiency. Revenue is growing at 6.3% YoY, while ROE of 16% signals solid shareholder returns.
Technically, the stock sits just below its 20‑day SMA (9.40) but comfortably above the 200‑day SMA (8.34), confirming a bullish longer‑term trend. Current price is near the identified support at €9.07 and well under the 52‑week high of €9.98, leaving upside potential of roughly 17%. The RSI of 51 indicates neutral momentum, while a bearish MACD histogram hints at short‑term caution. Volume is on an increasing trend, improving liquidity, and the beta of 0.59 points to lower market volatility. Recent news of a €650 million covered bond amendment and a notable shareholding change underscores active capital management without altering the fundamental outlook. Combined with a “Extreme Greed” sentiment index reading, the environment favors investors seeking yield and value. Overall, the blend of attractive valuation, robust cash generation, and modest risk makes the stock a compelling buy across horizons.

Market Outlook

Short Term

< 1 year
Positive
Model confidence: 7/10

Key Factors

  • price near support level of €9.07
  • high dividend yield of 5.4%
  • valuation discount vs industry peers

Medium Term

1–3 years
Positive
Model confidence: 8/10

Key Factors

  • target upside of ~17% toward €10.97
  • strong operating margins and cash position
  • sustainable dividend payout

Long Term

> 3 years
Positive
Model confidence: 9/10

Key Factors

  • solid ROE and consistent earnings growth
  • low leverage and ample cash reserves
  • stable dividend stream for income investors

Key Metrics & Analysis

Financial Health

Revenue Growth6.30%
Profit Margin47.21%
P/E Ratio8.4
ROE16.18%
ROA1.75%
P/B Ratio1.3
Industry P/E16.5

Technical Analysis

TrendBullish
RSI51.1
Support€9.07
Resistance€9.98
MA 20€9.40
MA 50€9.02
MA 200€8.34
MACDBearish
VolumeIncreasing
Fear & Greed Index89.14

Valuation

Target Price€10.97
Upside/Downside17.17%
GradeUndervalued
TypeBlend
Dividend Yield5.39%

Risk Assessment

Beta0.59
Volatility36.75%
Sector RiskMedium
Reg. RiskMedium
Geo RiskMedium
Currency RiskMedium
Liquidity RiskLow

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.